These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 28698044)
1. Resistance to first- and second-line antituberculosis drugs in Southern Taiwan: Implications for empirical treatment. Kuo CY; Wang WH; Huang CH; Chen YH; Lu PL J Microbiol Immunol Infect; 2018 Feb; 51(1):88-93. PubMed ID: 28698044 [TBL] [Abstract][Full Text] [Related]
2. Drug Resistance Characteristics of Wu X; Yang J; Tan G; Liu H; Liu Y; Guo Y; Gao R; Wan B; Yu F Front Cell Infect Microbiol; 2019; 9():345. PubMed ID: 31828045 [No Abstract] [Full Text] [Related]
3. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran. Velayati AA; Masjedi MR; Farnia P; Tabarsi P; Ghanavi J; ZiaZarifi AH; Hoffner SE Chest; 2009 Aug; 136(2):420-425. PubMed ID: 19349380 [TBL] [Abstract][Full Text] [Related]
4. Activity of twelve second-line antimicrobial agents against Mycobacterium tuberculosis in Taiwan. Lu PL; Peng CF; Hwang JJ; Chen YH J Chemother; 2008 Apr; 20(2):202-7. PubMed ID: 18467246 [TBL] [Abstract][Full Text] [Related]
5. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Caminero JA; Sotgiu G; Zumla A; Migliori GB Lancet Infect Dis; 2010 Sep; 10(9):621-9. PubMed ID: 20797644 [TBL] [Abstract][Full Text] [Related]
6. Limited Effect of Later-Generation Fluoroquinolones in the Treatment of Ofloxacin-Resistant and Moxifloxacin-Susceptible Multidrug-Resistant Tuberculosis. Lee H; Ahn S; Hwang NY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Kim CK; Koh WJ Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203478 [TBL] [Abstract][Full Text] [Related]
7. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan. Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012. Yin QQ; Jiao WW; Li QJ; Xu F; Li JQ; Sun L; Li YJ; Huang HR; Shen AD BMC Microbiol; 2016 May; 16():85. PubMed ID: 27176471 [TBL] [Abstract][Full Text] [Related]
9. Antibiotic Susceptibility Patterns of Mycobacterium tuberculosis Isolates from Guizhou Province of China Against 13 Antituberculosis Drugs. Li N; Liao X; Chen L; Wang J; Liu M; Zhang H Microb Drug Resist; 2015 Jun; 21(3):292-6. PubMed ID: 25599413 [TBL] [Abstract][Full Text] [Related]
10. First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant Varghese B; Al-Hajoj S Am J Trop Med Hyg; 2017 May; 96(5):1066-1070. PubMed ID: 28500800 [TBL] [Abstract][Full Text] [Related]
11. [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains]. Kayali R; Cöplü N; Ceyhan I; Ocak F; Citil BE; Esen B Mikrobiyol Bul; 2006; 40(1-2):1-7. PubMed ID: 16775950 [TBL] [Abstract][Full Text] [Related]
12. The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000. Lu PL; Lee YW; Peng CF; Tsai JJ; Chen YH; Hwang KP; Chen TP Int J Antimicrob Agents; 2003 Mar; 21(3):239-43. PubMed ID: 12636985 [TBL] [Abstract][Full Text] [Related]
13. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118 [TBL] [Abstract][Full Text] [Related]
14. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. API Consensus Expert Committee J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350 [TBL] [Abstract][Full Text] [Related]
15. [Using of the Sensititre MycoTB Plate Method for the Detection of Anti-tuberculous Drug Susceptibility of Rifampin Resistant Mycobacterium tuberculosis Complex Isolates]. Ceyhan İ; Vezir S Mikrobiyol Bul; 2020 Apr; 54(2):211-222. PubMed ID: 32723277 [TBL] [Abstract][Full Text] [Related]
16. Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design. Mok JH; Kang BH; Lee T; Lee HK; Jang HJ; Cho YJ; Jeon D J Korean Med Sci; 2017 Apr; 32(4):636-641. PubMed ID: 28244290 [TBL] [Abstract][Full Text] [Related]
17. Changing prevalence and resistance patterns in children with drug-resistant tuberculosis in Mumbai. Shah I; Shah F Paediatr Int Child Health; 2017 May; 37(2):135-138. PubMed ID: 27686119 [TBL] [Abstract][Full Text] [Related]
18. [Investigation of extensive drug resistance in multidrug resistance tuberculosis isolates]. Bektöre B; Haznedaroğlu T; Baylan O; Ozyurt M; Ozkütük N; Satana D; Cavuşoğlu C; Seber E Mikrobiyol Bul; 2013 Jan; 47(1):59-70. PubMed ID: 23390903 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011. Nguyen HB; Nguyen NV; Tran HT; Nguyen HV; Bui QT Western Pac Surveill Response J; 2016; 7(2):35-40. PubMed ID: 27508089 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of Pyrazinamide Resistance in Khyber Pakhtunkhwa, Pakistan. Khan MT; Malik SI; Ali S; Sheed Khan A; Nadeem T; Zeb MT; Masood N; Afzal MT Microb Drug Resist; 2018 Nov; 24(9):1417-1421. PubMed ID: 29584579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]